Clinical trial
Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
NCT04344951 is registered in ClinicalTrials.gov with Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial
- Lead sponsor
- Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 6, 2020
- Completion date
- November 30, 2020
- Enrollment
- 29 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.